A Phase II Study Of VB-1953 For The Treatment Of Moderate To Severe Facial Acne Vulgaris.
Phase of Trial: Phase II
Latest Information Update: 03 Jan 2019
At a glance
- Drugs VB 1953 (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- 03 Jan 2019 According to a Vyome Therapeutics media release, this trial is expected to initiate in the first quarter of 2019.
- 24 Apr 2017 According to a Vyome Biosciences media release, this trial is expected to begin by the end of 2017.
- 09 Feb 2017 New trial record